·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊÆ÷ÀÎÆ®¸ôTVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ÀϾç¾àÇ°, 3Q ¿µ¾÷ÀÍ 89¾ï¿ø...Àü³âºñ 4¹è Áõ°¡ ±â»çÀÔ·Â : 19.11.11 16:23:59 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=¾È°æÁø ±âÀÚ] ÀϾç¾àÇ°Àº Áö³ 3ºÐ±â ¿¬°á ±âÁØ ¿µ¾÷ÀÌÀÍ 89¾ï¿øÀ¸·Î Àü³âµ¿±â´ëºñ 4¹è °¡·® Áõ°¡Çß´Ù°í 11ÀÏ ºÐ±âº¸°í¼¸¦ ÅëÇØ °ø½ÃÇß´Ù. °°Àº ±â°£ ¸ÅÃâ¾×Àº 898¾ï¿øÀ¸·Î Àü³âº¸´Ù 15.1% ´Ã¾ú´Ù. ´ç±â¼øÀÌÀÍÀº 63¾ï¿øÀ» ±â·ÏÇß´Ù. ¾È°æÁø ±âÀÚ(kjan@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç HLBÁ¦¾à ¾à»ç(RA) ä¿ë ¹Ù·Î°¡±â 2024³â »ó¹Ý±â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â [ºñŸ¹ÎÇϿ콺] ¾à»ç °æ·ÂÁ÷ ä¿ë ¹Ù·Î°¡±â µ¿±¹»ý¸í°úÇÐ(ÁÖ) ¸¶ÄÉÆà ¾à»ç ¹× ¿¬±¸°³¹ß ¾à»ç ¿Ü ä¿ë ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â [Á¦Á¶°ü¸®¾à»ç/Ç°Áú°ü¸®¾à»ç]Áß°ßÁ¦¾à»ç(ÆòÅÃ) ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â 2024³â Á¦3Â÷ Á÷¿øä¿ë Àç°ø°í ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â µµ¸Å¾à»ç´Ô ¸ð½Ê´Ï´Ù ¹Ù·Î°¡±â BD¶óÀ̼¾½ÌÆÀ ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý ¹Ù·Î°¡±â µðÁöÅÐÇコÄɾî / Market Access / OTC¸¶ÄÉÆà / ÀÇ·á±â±â ¹Ù·Î°¡±â Sr. RA Specialist, RA Speaiclist ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀϾç¾àÇ°, 3Q ¿µ¾÷ÀÍ 89¾ï¿ø...Àü³âºñ 4¹è Áõ°¡ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀϾç¾àÇ°, 3Q ¿µ¾÷ÀÍ 89¾ï¿ø...Àü³âºñ 4¹è Áõ°¡ ±â»çÀÔ·Â : 19.11.11 16:23:59 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=¾È°æÁø ±âÀÚ] ÀϾç¾àÇ°Àº Áö³ 3ºÐ±â ¿¬°á ±âÁØ ¿µ¾÷ÀÌÀÍ 89¾ï¿øÀ¸·Î Àü³âµ¿±â´ëºñ 4¹è °¡·® Áõ°¡Çß´Ù°í 11ÀÏ ºÐ±âº¸°í¼¸¦ ÅëÇØ °ø½ÃÇß´Ù. °°Àº ±â°£ ¸ÅÃâ¾×Àº 898¾ï¿øÀ¸·Î Àü³âº¸´Ù 15.1% ´Ã¾ú´Ù. ´ç±â¼øÀÌÀÍÀº 63¾ï¿øÀ» ±â·ÏÇß´Ù. ¾È°æÁø ±âÀÚ(kjan@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç HLBÁ¦¾à ¾à»ç(RA) ä¿ë ¹Ù·Î°¡±â 2024³â »ó¹Ý±â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Medical ¹× Clinical °¢ ºÎ¹® ä¿ë ¹Ù·Î°¡±â [ºñŸ¹ÎÇϿ콺] ¾à»ç °æ·ÂÁ÷ ä¿ë ¹Ù·Î°¡±â µ¿±¹»ý¸í°úÇÐ(ÁÖ) ¸¶ÄÉÆà ¾à»ç ¹× ¿¬±¸°³¹ß ¾à»ç ¿Ü ä¿ë ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â [Á¦Á¶°ü¸®¾à»ç/Ç°Áú°ü¸®¾à»ç]Áß°ßÁ¦¾à»ç(ÆòÅÃ) ¹Ù·Î°¡±â Senior Clinical Research Associate ¹Ù·Î°¡±â Medical Communication & Strategy ¹Ù·Î°¡±â 2024³â Á¦3Â÷ Á÷¿øä¿ë Àç°ø°í ¹Ù·Î°¡±â [CSL Behring] Marketing Product Manager ¹Ù·Î°¡±â Ç°Áú°ü¸®¾à»ç / Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â ¼Ûµµ/¿À¼Û/ºÎ»ê Á¦Á¶/Ç°Áú°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â [CSL Behring] Medical Representative ¹Ù·Î°¡±â µµ¸Å¾à»ç´Ô ¸ð½Ê´Ï´Ù ¹Ù·Î°¡±â BD¶óÀ̼¾½ÌÆÀ ½ÅÀÔ/°æ·Â»ç¿ø ¸ðÁý ¹Ù·Î°¡±â µðÁöÅÐÇコÄɾî / Market Access / OTC¸¶ÄÉÆà / ÀÇ·á±â±â ¹Ù·Î°¡±â Sr. RA Specialist, RA Speaiclist ä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀϾç¾àÇ°, 3Q ¿µ¾÷ÀÍ 89¾ï¿ø...Àü³âºñ 4¹è Áõ°¡ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ÀϾç¾àÇ°, 3Q ¿µ¾÷ÀÍ 89¾ï¿ø...Àü³âºñ 4¹è Áõ°¡ ±â»çÀÔ·Â : 19.11.11 16:23:59 0 °¡ ÇÃÄ£Ãß°¡ [µ¥Àϸ®ÆÊ=¾È°æÁø ±âÀÚ] ÀϾç¾àÇ°Àº Áö³ 3ºÐ±â ¿¬°á ±âÁØ ¿µ¾÷ÀÌÀÍ 89¾ï¿øÀ¸·Î Àü³âµ¿±â´ëºñ 4¹è °¡·® Áõ°¡Çß´Ù°í 11ÀÏ ºÐ±âº¸°í¼¸¦ ÅëÇØ °ø½ÃÇß´Ù. °°Àº ±â°£ ¸ÅÃâ¾×Àº 898¾ï¿øÀ¸·Î Àü³âº¸´Ù 15.1% ´Ã¾ú´Ù. ´ç±â¼øÀÌÀÍÀº 63¾ï¿øÀ» ±â·ÏÇß´Ù. ¾È°æÁø ±âÀÚ(kjan@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ÀϾç¾àÇ°, 3Q ¿µ¾÷ÀÍ 89¾ï¿ø...Àü³âºñ 4¹è Áõ°¡ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö